> top > docs > PMC:7361216 > spans > 8034-8638 > annotations

PMC:7361216 / 8034-8638 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T93 63-70 Body_part denotes mannose http://purl.org/sig/ont/fma/fma82801
T94 111-130 Body_part denotes cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T95 364-371 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T28 111-130 Body_part denotes cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T19 151-169 Disease denotes multiple sclerosis http://purl.obolibrary.org/obo/MONDO_0005301
T20 289-309 Disease denotes inflammatory disease http://purl.obolibrary.org/obo/MONDO_0021166
T21 595-603 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T100 3-4 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T101 182-188 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T102 362-363 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T103 431-437 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T104 523-525 http://purl.obolibrary.org/obo/CLO_0007874 denotes MS

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T67 63-70 Chemical denotes mannose http://purl.obolibrary.org/obo/CHEBI_37684
T68 82-89 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154
T69 257-264 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T70 343-350 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154
T71 364-371 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T72 372-379 Chemical denotes carrier http://purl.obolibrary.org/obo/CHEBI_78059
T73 512-519 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154
T74 523-525 Chemical denotes MS http://purl.obolibrary.org/obo/CHEBI_73613

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T30 33-40 http://purl.obolibrary.org/obo/OGMS_0000031 denotes disease
T31 302-309 http://purl.obolibrary.org/obo/OGMS_0000031 denotes disease

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T59 63-70 Chemical denotes mannose http://purl.obolibrary.org/obo/CHEBI_37684
T60 82-89 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154
T61 343-350 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154
T62 364-371 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T63 512-519 Chemical denotes glycans http://purl.obolibrary.org/obo/CHEBI_18154

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T22 595-603 Species denotes COVID‐19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T52 0-219 Sentence denotes In a different neuroinflammatory disease antibodies to cryptic mannose containing glycans were observed in the cerebrospinal fluid of individuals with multiple sclerosis, and in its animal model EAE (Wang et al., 2014).
T53 220-310 Sentence denotes There again is some precedent for an antigen‐specific therapy for an inflammatory disease.
T54 311-462 Sentence denotes Injection of these oligomannose glycans coupled to a protein carrier reduced the clinical severity of paralysis in this animal model (Wang, Bhat et al.
T55 463-469 Sentence denotes 2014).
T56 470-604 Sentence denotes The success in parlaying the oligomannose glycans in MS and in its EAE model, could be emulated in strategies for therapy of COVID‐19.

LitCovid-sample-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T22 111-130 Body_part denotes cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
246 15-40 Disease denotes neuroinflammatory disease MESH:D003141
241 55-62 Gene denotes cryptic Gene:55997
242 63-70 Chemical denotes mannose MESH:D008358
243 82-89 Chemical denotes glycans MESH:D011134
247 151-169 Disease denotes multiple sclerosis MESH:D009103
244 330-350 Chemical denotes oligomannose glycans
248 413-422 Disease denotes paralysis MESH:D010243
245 499-519 Chemical denotes oligomannose glycans
249 595-603 Disease denotes COVID‐19 MESH:C000657245

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T89 362-371 Protein denotes a protein https://www.uniprot.org/uniprot/Q38365|https://www.uniprot.org/uniprot/P25244|https://www.uniprot.org/uniprot/P25243|https://www.uniprot.org/uniprot/P15966|https://www.uniprot.org/uniprot/P09676|https://www.uniprot.org/uniprot/P07394|https://www.uniprot.org/uniprot/P03632|https://www.uniprot.org/uniprot/P03610|https://www.uniprot.org/uniprot/O64306

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T93 63-70 Body_part denotes mannose http://purl.org/sig/ont/fma/fma82801
T94 111-130 Body_part denotes cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T95 364-371 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-sample-PD-MAT

Id Subject Object Predicate Lexical cue
T13 111-130 http://purl.obolibrary.org/obo/MAT_0000499 denotes cerebrospinal fluid

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T22 151-169 Disease denotes multiple sclerosis http://purl.obolibrary.org/obo/MONDO_0005301
T23 289-309 Disease denotes inflammatory disease http://purl.obolibrary.org/obo/MONDO_0021166
T24 595-603 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T14 413-422 Phenotype denotes paralysis http://purl.obolibrary.org/obo/HP_0003470

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T14 413-422 Phenotype denotes paralysis http://purl.obolibrary.org/obo/HP_0003470

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T52 0-219 Sentence denotes In a different neuroinflammatory disease antibodies to cryptic mannose containing glycans were observed in the cerebrospinal fluid of individuals with multiple sclerosis, and in its animal model EAE (Wang et al., 2014).
T53 220-310 Sentence denotes There again is some precedent for an antigen‐specific therapy for an inflammatory disease.
T54 311-462 Sentence denotes Injection of these oligomannose glycans coupled to a protein carrier reduced the clinical severity of paralysis in this animal model (Wang, Bhat et al.
T55 463-469 Sentence denotes 2014).
T56 470-604 Sentence denotes The success in parlaying the oligomannose glycans in MS and in its EAE model, could be emulated in strategies for therapy of COVID‐19.

LitCovid-sample-Glycan

Id Subject Object Predicate Lexical cue
T3 63-70 http://rdf.glyconavi.org/CarTNa/CarTNa218/trivialname denotes mannose

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
241 55-62 Gene denotes cryptic Gene:55997
242 63-70 Chemical denotes mannose MESH:D008358
243 82-89 Chemical denotes glycans MESH:D011134
244 330-350 Chemical denotes oligomannose glycans
245 499-519 Chemical denotes oligomannose glycans
246 15-40 Disease denotes neuroinflammatory disease MESH:D003141
247 151-169 Disease denotes multiple sclerosis MESH:D009103
248 413-422 Disease denotes paralysis MESH:D010243
249 595-603 Disease denotes COVID‐19 MESH:C000657245